Loading organizations...
Aulis Capital is a global investment firm specializing in the healthcare industry. The firm builds value by partnering with early and growth stage companies, employing deep scientific, analytical, and investment expertise. This approach accelerates the development of innovations designed to improve patient care and advance medical technology across diverse global markets.
The firm's inception is rooted in the extensive experience of its founding Managing Partner, Nisa Leung. Leveraging a distinguished career that includes founding and leading the healthcare practice at Qiming Venture Partners since 2006, Leung established Aulis Capital to apply a comprehensive understanding of the sector. Her insight was to create a platform that strategically combines capital with profound industry knowledge to foster critical advancements.
Aulis Capital serves visionary entrepreneurs and innovative companies within the healthcare ecosystem seeking strategic capital and operational guidance. The firm's overarching vision is to construct a healthier and more equitable world. By investing in transformative innovations, Aulis Capital aims to drive significant progress in human health and deliver impactful solutions globally.
Aulis Venture has 1 tracked investment across 1 company. The latest tracked deal is $3.0M Seed in blackbox in January 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | blackbox | $3.0M Seed | Michael Arrington, Edward TAN | Better Tomorrow Ventures, CrunchFund, First Round Capital, Florida Funders, Thirty Five Ventures, Matt Mazzeo, TIM Ferriss, Keone HON, Tang Hongbo, Arcane Group, CMS Holdings, Benjamin Lavergne, Draper Dragon, Flow Traders, Formless Capital, Laser Digital, Manifold Trading, Mask Network, ONE Piece Labs, Press Start Capital, Vessel Capital |
